We investigated the role of leptin receptor (Ob-R) and its relationship with phosphatidylinositol 3-kinase (PI3K)/AKT activation in colorectal carcinomas (CRCs) tissues followed by in vitro studies using a panel of CRC cell lines. Obesity serves an important risk factor of several cancers including CRC that ranks as the second most common cancer in Saudi Arabia. High levels of adipokine leptin (Ob) and its Ob-R are seen in obesity and also in various carcinomas including CRC. We investigated the proliferative and antiapoptotic effect of Ob on human CRC cell lines Caco-2, HT-29 and SW-840 and the role of PI3K/AKT-signaling pathway in mediating these actions. Then the expression of Ob-R and its relationship with clinicopathological features was analyzed in 448 CRC, 229 normal colon mucosa and 24 colorectal adenomas using tissue microarray technology. Treatment with Ob resulted in increased proliferation of CRC cell lines and involved activation of PI3K/AKT-signaling pathway. Pretreatment with Ob-R small interfering RNA or PI3K inhibitor inhibited these responses. Ob-R was significantly overexpressed in primary CRC relative to adenomas and normal colonic mucosa. In primary CRC, Ob-R significantly correlated with Ob expression, early stage and well-differentiated tumors. Intriguingly, patient with Ob-R positive tumors showed significantly better overall survival (P 5 0.0098). Ob plays a critical role in CRC carcinogenesis through PI3K/AKT pathway via Ob-R. Ob-R is a prognostic marker associated with better survival.
Introduction
Colorectal carcinoma (CRC) is a major cause of mortality and morbidity worldwide. In Saudi Arabia, the incidence of CRC is increasing, whereas the incidence rate was originally lower than in Western countries. According to latest statistics, CRC is considered the second most common cancer among Saudi males and the third most common among Saudi females (1, 2) . So, we believe that population like Saudis, in which dramatic changes in cancer incidence have occurred, may offer a unique opportunity to identify gene-environmental interaction. It is highly improbable that genetic factors alone can explain increase in CRC incidence rate over the past two decades, suggesting role of environmental factors, including obesity as an etiological factor. There is a known association between colon cancer and obesity (3, 4) . Many factors including those related to lifestyle may underlie this association, but factors produced by the increased fat mass may be involved. Prevalence of obesity is high in Saudi Arabia among both genders and the reported incidence is 33.9% (5) . Leptin (Ob), the product of obesity gene, is a 16 kDa adipokine produced predominantly by adipocytes that regulates food intake and energy expenditure (6) . The adipokine Ob is elevated in the serum of obese people in direct correlation to fat mass (7) and may be an important biological link between obesity and colon cancer. Recent evidence suggests that high serum Ob levels are independent risk factor for colonic cancer (8) . However, the effect of Ob on the colonic mucosa is complex. Role of Ob in colon carcinogenesis is not yet fully understood, and contradictory data have been reported in the animal model (9) (10) (11) . Similarly, conflicting reports exist about the role of leptin receptor (Ob-R) as a prognostic biomarker in CRC (12) (13) (14) (15) .
Ob exerts its activity through specific membrane receptor, the obesity or leptin receptor (Ob-R), which is assigned to class I cytokine receptor family (16) . Six splice variants of Ob-R have been identified up to now; a long isoform, four short isoforms discriminated by the different lengths of intracellular domain and the secreted isoform, which modulates blood Ob (16, 17) . According to the current knowledge, Ob-signaling pathway is mainly transduced by janus kinases/ signal transducers and activators of transcription, mitogen-activated protein kinase and phosphatidylinositol 3-Kinase (PI3K)-signaling pathways (18) .
PI3K/AKT pathway may be set off through the activation of receptor tyrosine kinases by certain growth and survival factors (including Ob), through the activation of non-receptor tyrosine kinases or through Ras-signaling pathway activation (19) . Activated PI3K phosphorylates phosphatidylinositol-3, 4-biphosphate and phosphatidylinositol-3, 4, 5-triphosphate. Phosphatidylinositol-3, 4-biphosphate and phosphatidylinositol-3, 4, 5-triphosphate activate a downstream target of PI3K namely AKT kinase that subsequently activate other targets including glycogen synthase kinase 3, FoxO1 and p27 kip1 .
Previously, we have shown that aberrant PI3K/AKT-signaling activation plays a critical role in Middle Eastern CRC tumorigenesis and progression (20) . We therefore sought to assess if Ob could be involved in Middle Eastern CRC carcinogenesis by activating PI3K/ AKT kinase pathway through Ob-R. Therefore, in the present study, we analyzed simultaneously the prevalence of Ob-R expression and its correlation with expression patterns of PI3K/AKT pathway proteins as well as other clinicopathological variables in large cohort of Saudi CRC patient samples. We further conducted in vitro analysis to examine the expression of Ob-Rs using CRC cell lines and then we investigated the effect of Ob on malignant properties of CRC including proliferation and inhibition of apoptosis. We further examined the involvement of PI3K/AKT in colonic epithelial Ob signaling.
Materials and methods
Patient selection and tissue microarray construction A total of 448 patients with CRC diagnosed between 1990 and 2006 were selected from King Faisal Specialist Hospital and Research Centre. All CRC, 24 adenomas and 229 adjacent normal colorectal mucosa were analyzed in a tissue microarray format. Clinical and histopathological data were available for all these patients. Long-term follow-up data were provided by Colorectal Unit, Department of Surgery. Tissue microarrays were constructed from formalin-fixed, paraffin-embedded colorectal carcinoma specimens as described previously (20) . One pathologist reviewed all tumors for grade and histological subtype. Institutional Review Board of King Faisal Specialist Hospital and Research Centre approved the study.
Immunohistochemistry
Tissue microarray slides were processed and stained manually. The streptavidinbiotin peroxidase technique with diaminobenzidine as chromogen was applied. For antigen retrieval, Dako Target Retrieval Solution pH 9.0 (Catalogue number Abbreviations: AJCC, American Joint Committee on Cancer; BCL-XL, basal cell lymphoma-extra large; CRC, colorectal carcinoma; p-FoxO1, forkhead box O1; IHC, immunohistochemistry; Ob, leptin; Ob-R, obesity or leptin receptor; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; PTEN, phosphatase and tensin homolog; PI3K, phosphatidylinositol 3-kinase; siRNA, small interfering RNA; XIAP, X-linked inhibitor of apoptosis protein. Endogenous peroxidase activity was quenched using 3% hydrogen peroxidase. Endogenous biotin was blocked and all slides were counterstained with hematoxylin, dehydrated, cleared and cover slipped with premount. Only fresh cut slides were stained simultaneously to minimize the influence of slide ageing and maximize repeatability and reproducibility of the experiment.
Immunohistochemistry assessment
Ob-R expression was categorized by doing an H score (21) . Each tissue microarray spot was assigned an intensity score from 0 to 3(I 0 , I 1-3 ) and proportion of the tumor staining for that intensity was recorded as 5% increments from a range of 0-100(P 0 , P 1-3 ). A final H score (range 0-300) was obtained by adding the sum of scores obtained for each intensity and proportion of area stained (H score 5 I 1 XP 1 þI 2 XP 2 þI 3 XP 3 ). CRCs were grouped into two groups based on X-tile plots: one with complete absence or reduced staining (H score 5 0-40) and the other group showed overexpression (H score .40) depending on the H score. Similarly, X-tile plots were used to stratify the CRC cases into two groups for X-linked inhibitor of apoptosis protein (XIAP), Basal cell lymphoma-extra large (BCL-XL), an antiapoptotic protein of the Bcl-2 family and forkhead box O1 (p-FoxO1). p-AKT and phosphatase and tensin homolog (PTEN) scoring was done as described earlier (20, 22) . X-tile plots were constructed for assessment of biomarker and optimization of cutoff points based on outcome as has been described earlier (23) (24) (25) .
Statistical analysis
The JMP7 (SAS Institute, Cary, NC) software package was used for data analyses. Survival curves were generated using the Kaplan-Meier method, with significance evaluated using the Mantel-Cox log-rank test. Risk ratio was calculated using the Cox proportional hazard model in both univariate and multivariate analyses. Chi-square tests were used to examine relationship between nominal variables. The limit of significance for all analyses was defined as a P-value of 0.05.
Cell culture
Caco-2, HT29 and SW-480 cells were cultured in RPMI 1640 medium supplemented with 10% (vol/vol) fetal bovine serum, 100 U/ml Penicillin and 100 U/ml Streptomycin at 37°C in humidified atmosphere containing 5% CO 2 .
Reagents and antibodies 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) was purchased from Sigma (St Louis, MO). Ob-R antibody was purchased from Abcam (Cambridge, UK). Antibodies against phospho-AKT and phospho-FKHR, phospho-glycogen synthase kinase 3 antibodies were purchased from Cell Signaling Technologies (Beverly, MA). Beta-actin, BCL-XL antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-XIAP antibody was purchased from R&D Systems (Minneapolis, MN). Annexin V kit was purchased from Molecular Probes (Eugene, OR). Apoptotic DNAladder kit was obtained from Roche (Penzberg, Germany).
MTT assays A total of 10 4 cells were incubated in triplicate in a 96-well plate in the presence or absence of indicated test doses of Ob in a final volume of 0.20 ml for 48 h. The ability of Ob to induce cell growth was determined by MTT cell proliferation assays, as described previously (26) . Replicates of six wells for each dosage including vehicle control were analyzed for each experiment.
Annexin V/propidium iodide dual staining CRC cell lines were treated with the indicated concentrations of Ob in conditions treated as indicated in Figures 4 and 5 legends. The cells were harvested and the percentage of cells undergoing apoptosis was measured by flow cytometry after staining with fluorescein-conjugated Annexin V/propidium iodide as described previously (26) .
Cell lysis and immunoblotting
Cells were treated either with Ob or Ob in combination with PI3K inhibitor LY294002 as described in the legends and lysed as described previously (27) . Proteins (15-20 lg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membrane (Immobilon, Millipore, Billerica, MA). Immunoblotting was done with different antibodies and visualized by the enhanced chemiluminescence (Amersham, Piscataway, NJ) method.
Gene silencing using small interfering RNA Ob-R small interfering RNA (siRNA) and scrambled control siRNA were purchased from Qiagen (Valencia, CA). Cells were transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) and siRNA for 6 h following which the lipid and siRNA complex was removed and fresh growth medium was added and incubated for 48 h. Cells were starved for 24 h and then treated with or without Ob as indicated and after lysis, protein levels were determined by western blot analysis with specific antibodies.
Results

Immunohistochemical detection of Ob-R expression
Levels of Ob-R were examined by immunohistochemistry (IHC) in a series of 448 CRC. High levels of Ob-R expression were seen in 87.3% (344/394) CRC, 58.3% (14/24) colorectal adenomas and in 5.2% (12/ 229) normal colorectal mucosa specimens ( Figure 1) . Thus, the incidence as well as mean expression levels of Ob-R were more in CRC (mean 141.95 ± 80.59) as compared with colorectal adenomas (59.58 ± 11.88; P , 0.0001). Similarly, Ob-R expression was more in adenomas as compared with adjacent normal colorectal mucosa (9.06 ± 21.09; P 5 0.0004). Thus, our results suggested a progressive increase in Ob-R expression during colorectal carcinogenesis ( Figure 2A ).
Association of Ob-R with PI3K/AKT pathway proteins Although no significant association was observed with p-AKT expression by IHC, a direct association was found with normal PTEN expression (P 5 0.0360). In addition, Ob-R expression was significantly correlated with downstream targets of PI3K-signaling pathway such as p-FoxO1 (P 5 0.0107), antiapoptosis markers XIAP (P , 0.0001) and BCL-XL (P , 0.0001; Table I ).
Ob-R correlation with clinicopathological parameters Ob-R expression was correlated with various clinicopathological parameters and the results are presented in Table I . Ob-R expression was more common in adenocarcinomas as compared with mucinous carcinoma (P 5 0.0009). Ob-R overexpression was significantly more common in well-differentiated CRCs (P 5 0.0001) and was associated with an early American Joint Committee on Cancer (AJCC) stage (P 5 0.0191) and absence of metastasis CRCs (P 5 0.0396). No association was observed with age, gender, site, tumor size and body mass index. Patients with Ob-R expression had an improved overall survival than those with reduced Ob-R expression ( Figure 2B ). Patients with overexpression of Ob-R had a better overall survival of 65.2% at 5 years as compared with 59.8% with reduced Ob-R expression. (P 5 0.0098). In the multivariate analysis using Cox proportional hazard model for multiple factors like age, gender, AJCC stage, grade and Ob-R expression, the relative risk was 1.30 for Ob-R overexpression (95% confidence interval 0.74-2.28; P 5 0.3724) and 6.31 for advanced AJCC stage (95% confidence interval 3.57-11.13; P 5 ,0.0001). Thus, Ob-R was not an independent prognostic marker in multivariate analysis (supplementary Table 2 is available at Carcinogenesis Online).
Ob increase proliferation of CRC cells
The effects of Ob on growth rate of a panel of colon cell lines were determined using MTT assay. Caco-2, HT-29 and SW480 were initially serum starved for 24 h and then stimulated with various doses of recombinant Ob (10-100 ng/ml) for 48 h compared with cell serumfree control cultures. As shown in Figure 3A , Ob induced significant cell growth of all colon cell lines in a dose-dependent manner.
Ob prevent serum-starved apoptosis in CRC cells CRC cell lines were seeded in six-well plates and after 24 h, serum-free medium alone or 100 ng/ml Ob was added. After 48 h, apoptosis was measured by annexin/propidium iodide staining and cell death was measured by trypan blue exclusion dye. As shown in Figure 3B and C, serum starvation resulted in apoptosis and cell death in all CRC cell line and Ob treatment prevented serum-starved apoptosis and cell death suggesting that Ob counteract apoptosis and cell death in CRC cell lines.
Ob activates the PI3K/AKT-signaling pathway PI3K pathways have been implicated in playing crucial roles in regulating cell growth, cell proliferation prevention of apoptosis, which altogether attribute to tumorigenesis (19) . In view of these findings, Leptin and colorectal carcinoma we sought to determine whether PI3K signaling is activated during Ob-stimulated CRC cell line proliferation. Caco-2 cells were stimulated with 100 ng/ml Ob for various time periods. Cells were lysed and proteins were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotted with p-AKT (activated AKT) and p-FOXO1 antibodies. As shown in Figure 4A , Ob treatment of Caco-2 phosphorylated AKT and FOXO1 as early as 30 min and remained phosphorylated till 6 h. Similar results were obtained with other CRC cell lines (data not shown).
Inhibition of PI3K abrogated Ob-induced CRC proliferation, inhibits its antiapoptotic effects and prevents AKT activation and its downstream effector FOXO1 Since our hypothesis for this study is whether Ob-stimulated PI3K signaling plays a role in CRC proliferation and promotes its antiapoptotic effects, therefore, we sought to determine whether the inhibition of PI3K by its specific inhibitor, LY294002, abrogated Ob-induced cell proliferation and its antiapoptotic effects on CRC cell lines. Cells were seeded on culture plates for 24 h. Starved CRC cells were pretreated with 25 lM LY294002 for 2 h and subsequently treated with and without 100 ng/ml Ob for 48 h. Cell proliferation was measured by MTT assays and apoptosis was measured by annexin/ propidium iodide staining. As shown in Figure 4B and C, pretreatment of CRC cell lines with LY294002 abrogated Ob-induced cell proliferation as well its antiapoptosis effects. In the subsequent experiment, we determined the status of Ob-activated AKT and FOXO1 phosphorylation in response to PI3K inhibition by LY294002. CRC cells were pretreated with 25 lM LY294002 for 2 h and subsequently treated with 100 ng/ml leptin for 3 h. Cells were lysed and proteins were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotted with antibodies against p-AKT and p-FOXO1. As shown in Figure 4D , Ob strongly phosphorylated AKT and FOXO1 in all the CRC cell lines and pretreatment with LY294002 prevented AKT and FOXO1 phosphorylation suggesting that PI3K/AKT pathway plays a critical role in Ob-induced growth and proliferation of CRC cell lines. These data also suggest that Ob is acting upstream of PI3K/AKT pathway in modulating its cell proliferative and antiapoptotic response in CRC cell lines.
CRC cell lines express Ob-R that mediates the PI3K/AKT-signaling pathways To investigate whether Ob-Rs are functional and linked to coordinate with PI3K/AKT-signaling pathway to regulate cell growth and proliferation of CRC cell lines, we utilized siRNA strategies to transfect Ob-R-specific siRNA as well as scrambled non-specific siRNA in HT-29 CRC cell line. After 48 h transfection, cells were starved and then treated with and without 100 ng/ml Ob for 3 h. As shown in Figure 5 , HT-29 expressed functional Ob-Rs, as described previously (28) . Treatment of scrambled siRNA harboring HT-29 cells with Ob showed activation of AKT and elevated level of XIAP and BCL-XL proteins that are either involved in PI3K/AKT pathway or play a critical role in cell survival. On the other hand, expression of Ob-Rspecific siRNA in HT-29 cells knocked down the expression of Ob-R and prevented Ob-induced activation of AKT as well as abrogated the expression of XIAP and BCL-XL proteins. These data confirm our finding that Ob utilizes PI3K/AKT signal transduction pathway in mediation of CRC cell proliferation, further confirming our finding These data are also suggesting that Ob is acting upstream of PI3K/AKT pathway in CRC cell lines.
Discussion
Recent reports suggested that Ob, a hormone whose expression is elevated in overweight and obese individuals, might be involved in the development and/or progression of different cancers. These concepts are supported by experimental evidence that Ob can stimulate growth and prevent apoptosis in different cellular cancer models including colorectal cancer (28) (29) (30) (31) . A number of earlier studies have given conflicting data about the role of Ob/Ob-R in colon carcinogenesis in animal models and also about the role of Ob-R and or Ob as a prognostic marker in CRC (9-15,28,32,33) .
However, the potential role of Ob/Ob-R in the pathogenesis of Middle Eastern CRC has not been fully elucidated. Therefore, we first examined Ob-R expression in 448 CRC samples. Ob-R protein expression has been detected in 344/394 (87.3%) of CRCs studies (Table I) . Immunostaining for Ob-R was significantly higher (P 5 0.0001) in well-differentiated compared with poorly differentiated CRCs; also expression was higher in early stage (P 5 0.0191) and more common in adenocarcinomas as compared with mucinous carcinoma (P 5 0.0009), which all suggest the involvement of Ob/ Ob-R as tumor-initiating event in Middle Eastern CRC tumorigenesis (Table I) . No association was seen with body mass index (data not shown), age and gender of the patient. This is partially in agreement with previous report (15) . Interestingly, downregulation of Ob-R expression in less differentiated tumors was observed by other authors in CRC (15) and in gastric adenocarcinomas (34) , which further suggest that Ob and Ob-R might have a founder event in CRC tumorigenesis and might also indicate a trend for silencing Ob expression during differentiation of gastric and CRC.
However, the striking finding in this study is that patients with high Ob-R-expressing tumors showed an extremely good outcome, and the survival rate is significantly higher (P 5 0.0098) in patients with high Ob-R expression. It might seem paradoxical that a tumor containing receptors for mitogenic factor such as Ob had a better prognosis as compared with tumors without Ob-R expression; one speculation could be that tumors with Ob-R have retained some physiological growth control by Ob that could explain the better prognosis. This hypothesis is sustained by the strong link between Ob-R and differentiation. Furthermore, these results are in agreement with earlier reports by Aloulou et al., who have shown that Ob-R overexpression in CRC was associated with an improved progression free survival. In addition, in their study cohort of 171 CRC, Ob-R expression was significantly higher in CRC with microsatellite instability-H phenotype. Aloulou et al. (14) and Abolhassani et al. (13) further suggest that the density of Ob-R on tumor colon cells influences cytokine and chemokine releases from these cells, which in turn can recruit and stimulate immune cytotoxic cell. This is consistent with the observation that tumors with microsatellite instability-H phenotype are known to be associated with improved patient outcome, probably due to higher lymphocyte recruitment in the tumor microenvironment (35) . However, in our study, we did not observe any correlation between Ob-R expression and microsatellite instability-H phenotype (data not shown), which could be attributable to possible ethnic differences. Paik et al. (12) have also shown that Ob expression along with patient age, differentiation, AJCC stage, lymphatic invasion and vascular invasion were significantly associated with overall survival and disease-free survival in univariate and/or multivariate analyses. Thus, differences in sample size, methodology used to assess Ob or Ob-R, target studied-Ob or Ob-R, and possibly ethnic differences could explain some of the conflicting results. Furthermore, as more Leptin and colorectal carcinoma is learned about Ob-R and its ligand Ob, defining their potential role in tumor progression becomes more difficult. The multifunctional effects of Ob signaling has been shown to depend upon the in vivo circumstances, Ob concentrations, tumor cell differentiation and finally upon a delicate balance between epithelial and lymphoid (immune) compartments.
We then also examined the relationship between the expression of Ob-R and the expression of PI3K/AKT pathway protein targets in CRC. Several previous studies have suggested Ob/Ob-R exerts its oncogenic effect by activation of PI3K/AKT pathway. So as a read out of PI3K functional activation, we screened level of AKT phosphorylation status by IHC in a large cohort of CRC. Surprisingly, in our study, there was a lack of statistical significance when correlating pAKT by IHC staining in tumors with Ob-R expression. An explanation that could be offered is upstream signaling pathways other than Ob/Ob-R pathway can also be involved in the activation of AKT. However, Ob-R overexpression was correlated with other downstream targets of PI3K/AKT like p-FOXO1, BCL-XL and XIAP (P 5 0.0107, P , 0.0001 and P , 0.0001, respectively). Interestingly, tumors that overexpress Ob-R have normal PTEN expression (P 5 0.0360). Previously it has been reported that normal PTEN expression is seen in early stage and well-differentiated tumors (36) . The significant link between Ob-R and normal PTEN expression is a further indication that Ob-R deregulation might be involved as a tumor initiating events.
After documenting that obesity hormone Ob-R is overexpressed in Saudi CRC, we then tried to elucidate the molecular mechanisms of Ob action and signaling pathways involved in CRC. We conducted in vitro studies using a panel of human CRC cell lines. Our data confirmed that Ob in vitro stimulates proliferation (Figure 3 ) and thus h, serum-free medium alone or 10, 25, 50 and 100 ng/ml of Ob as indicated was added. After 48 h, cell proliferation was measured by MTT assay as described in Materials and Methods. The graph displays the mean ± SD of six independent experiments. (B) CRC cell lines were seeded in six-well plates and after 24 h, serumfree medium alone or 100 ng/ml of recombinant Ob was added. After 48 h, apoptosis was measured by annexin/propidium iodide staining. (C) CRC cell lines were seeded in six-well plates and after 24 h, serum-free medium alone or 100 ng/ml of recombinant Ob was added and incubated for another 48 h. Percentage cell death was scored using trypan blue exclusion dye. The graph displays the mean ± SD of six independent experiments. Ã P , 0.05, statistically significant (Student's t-test).
Leptin and colorectal carcinoma is a growth factor for these cells as previously reported (30) . The antiapoptotic effect of Ob demonstrated in Figure 4 , further confirms that the mitogenic role of Ob treatment is indeed due to combination of stimulation of cell proliferation and inhibition of apoptosis by Ob. These findings are in agreement with previous reports in the literature (30) . We also examined the involvement of PI3K/AKT in Ob signaling in CRC cells (Figure 4) . Inhibition of PI3K abrogated Ob-induced cell proliferation as well as antiapoptotic effect in CRC cell lines. In addition, gene silencing of Ob-R by Ob-R-specific siRNA inactivated AKT-signaling pathways. These data suggest that this kinase pathway is activated by Ob upon binding to its receptor and it consequently mediates the proliferative and antiapoptotic effects. As expected, the specific pharmacological inhibitor of PI3K (LY294002) inhibited AKT phosphorylation and Ob-mediated antiapoptotic effect. Interestingly, Ob's downregulation with Ob-R siRNA abolished AKT phosphorylation showing that Ob-R is upstream of AKT in colonic epithelial Ob signaling ( Figure 5) . The mechanisms by which Ob-R siRNA decreases AKT activity is not clear. One possible explanation is that Ob can also act through some of the components of the insulinsignaling cascade, although reports disagree about its importance in modifying insulin-induced gene expression. Insulin itself acts through its receptor by recruiting different insulin receptor substances that are tyrosine phosphorylated by the intrinsic kinase activity of the receptor. Phosphorylation of insulin receptor substances increases the affinity by which they bind other signaling molecules and initiates further steps on the pathway (37) .
The molecular mechanism responsible for Ob overexpression in colorectal cancer and binding capacity of Ob-R for Ob in CRC, adenomas and normal adjacent mucosa is not fully understood. Attoub et al. (38) described Ob messenger RNA in normal mucosa, polyps and colorectal adenocarcinomas but did not quantify Ob protein expression and its correlation with cancer progression. Our results suggest that in normal colonic epithelium and colorectal adenomas Ob-R expression is relatively weak, but the receptor is overexpressed in colorectal cancer. In the presence of an overexpressed receptor and probably higher leptin levels, the leptin system might promote cancer progression in an autocrine and paracrine manner (39, 40) . Hypoxia, which is a ubiquitous phenomenon in most cancers, also could lead to high leptin expression in colon cancer tissue. Indeed, in several cellular systems, including breast and colon cancer cells, leptin messenger RNA expression is induced by hypoxia, and the leptin gene promoter is regulated by hypoxia-inducible factor-1a (41) . The in vitro effects of leptin signaling through Ob-R in colorectal cancer cell lines are well characterized. Leptin in vitro stimulate proliferation and has an antiapoptotic effect as previously reported (30) . The activation of Ob-R in cell lines and subsequent induction of multiple signaling cascades, such as the janus kinases 2/signal transducers and activators of transcription 3, extracellular signal-regulated kinase1/2, protein kinase C-alpha and Akt/glycogen synthase kinase 3 pathways, have been shown to stimulate cell growth, transformation and survival (42) (43) (44) .
The in vivo effects of leptin, however, are quite complex as they are influenced by multiple factors. Leptin triggers an inflammatory response in tumor tissue by directly stimulating colonocytes, which can recruit T cytotoxic cells in the tumor microenvironment. It targets Ob-R, its main receptor on colonocytes (32, 33, 45) , and may induce the expression of nuclear factor-jB, activation of which leads to both cell proliferation (45) and production of proinflammatory cytokines and chemokines (45, 46) . Ob also targets the lymphocytes, within which it may stimulate development, differentiation, proliferation, activation and cytotoxicity (47, 48) . In animals, exogenous Ob has been shown to promote experimental colitis by targeting colonocytes and lymphocyte cells, but its role in colon carcinogenesis is not yet fully understood and contradictory data have been reported (9) (10) (11) 49, 50) . Mice with recessive ob mutations have non-functional leptin/obese receptor and display increased susceptibility to spontaneous tumors (50) , which could be associated with decreased systemic or intestinal immune function (46, 49) . It has been suggested that Ob may be protumorigenic in wild-type animals because of its proliferative effect on the intestine (28) . However, in spite of this proliferative effect, it fails to exercise a protumorigenic role (32, 33) and that overexpression of the Ob-R in colorectal cancer is associated with a better prognosis (14) , suggesting that colonocytes could be a source of the proimmune response in colorectal cancer.
In summary, high prevalence of Ob-R deregulation was seen in large Saudi cohort of CRC and Ob-R overexpression was a prognostic marker for better survival for Middle Eastern CRC. Further, our in vitro data suggest that increase in Ob/Ob-R levels might enhance the growth of colonic cancer cell and this effect at least in part may be mediated by PI3K/AKT pathway. These results might provide the link between increased incidence of obesity and increased risk of CRC in Saudi Arabia.
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